BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9162742)

  • 1. Investigation of plasma membrane-associated apolipoprotein E in primary macrophages.
    Deng J; Rudick V; Rudick M; Dory L
    J Lipid Res; 1997 Feb; 38(2):217-27. PubMed ID: 9162742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
    Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
    J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal degradation and sorting of apolipoprotein E in macrophages.
    Deng J; Rudick V; Dory L
    J Lipid Res; 1995 Oct; 36(10):2129-40. PubMed ID: 8576639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
    Seo T; St Clair RW
    J Lipid Res; 1997 Apr; 38(4):765-79. PubMed ID: 9144091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS; Fazio S; Lee YL; Mahley RW
    J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E.
    Lucas M; Mazzone T
    J Biol Chem; 1996 Jun; 271(23):13454-60. PubMed ID: 8662812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells.
    Lilly-Stauderman M; Brown TL; Balasubramaniam A; Harmony JA
    J Lipid Res; 1993 Feb; 34(2):190-200. PubMed ID: 8381453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE of the HepG2 cell surface includes a major pool associated with chondroitin sulfate proteoglycans.
    Burgess JW; Liang P; Vaidyanath C; Marcel YL
    Biochemistry; 1999 Jan; 38(2):524-31. PubMed ID: 9888791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
    Ji ZS; Sanan DA; Mahley RW
    J Lipid Res; 1995 Mar; 36(3):583-92. PubMed ID: 7539827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype.
    Campbell JH; Rennick RE; Kalevitch SG; Campbell GR
    Exp Cell Res; 1992 May; 200(1):156-67. PubMed ID: 1563484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans.
    Hara M; Matsushima T; Satoh H; Iso-o N; Noto H; Togo M; Kimura S; Hashimoto Y; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):269-74. PubMed ID: 12588770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between proteoglycans and apoE on the HepG2 cell surface].
    Liang P; Burgess JW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):320-3. PubMed ID: 12940068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HepG2 extracellular matrix contains separate heparinase- and lipid-releasable pools of ApoE. Implications for hepatic lipoprotein metabolism.
    Burgess JW; Gould DR; Marcel YL
    J Biol Chem; 1998 Mar; 273(10):5645-54. PubMed ID: 9488694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL receptor binds newly synthesized apoE in macrophages. A precursor pool for apoe secretion.
    Zhao Y; Mazzone T
    J Lipid Res; 1999 Jun; 40(6):1029-35. PubMed ID: 10357834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells.
    Schmitt M; Grand-Perret T
    J Lipid Res; 1999 Jan; 40(1):39-49. PubMed ID: 9869648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e.
    Paka L; Kako Y; Obunike JC; Pillarisetti S
    J Biol Chem; 1999 Feb; 274(8):4816-23. PubMed ID: 9988721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface.
    Burgess JW; Marcel YL
    J Lipid Res; 2001 Sep; 42(9):1413-20. PubMed ID: 11518760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages.
    Dory L
    J Lipid Res; 1991 May; 32(5):783-92. PubMed ID: 2072040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins.
    Halvorsen B; Aas UK; Kulseth MA; Drevon CA; Christiansen EN; Kolset SO
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):743-52. PubMed ID: 9560300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.